Aprea Therapeutics
APRE
$5.27
Share price
-3.48%
Change (1 day)
37.24%
Change (1 year)
Categories
Market capitalization of Aprea Therapeutics (APRE)
Market cap: $28.61 Million
As of May 2024 Aprea Therapeutics has a market cap of $28.61 Million. This makes Aprea Therapeutics the world's 7915th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Aprea Therapeutics from 2019 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $28.61 M | 62.95% |
| 2023 | $17.56 M | 0.11% |
| 2022 | $17.54 M | -71.52% |
| 2021 | $61.6 M | -40.9% |
| 2020 | $0.10 B | -89.18% |
| 2019 | $0.96 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Aprea Therapeutics was reported to be:
$28.61 Million
$28.61 Million
$28.61 Million
$30.35 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Magellan Health
MGLN | $2.50 B | 8,640.48% | 🇺🇸 USA |
 Amedisys AMED | $3.08 B | 10,682.58% | 🇺🇸 USA |
 Healthcare Services Group HCSG | $0.84 B | 2,869.81% | 🇺🇸 USA |